news
The ISCT is objecting linking the benefits of cellular immunotherapy…
8 August 2019 | By Rachael Harper (Drug Target Review)
The ISCT is objecting linking the benefits of cellular immunotherapy with third party offerings of T-cell banking for future therapeutics.